170 related articles for article (PubMed ID: 26152179)
1. Primary and Secondary Prevention of Acute Coronary Syndromes: The Role of the Statins.
Diamantis E; Troupis T; Mazarakis A; Kyriakos G; Diamanti S; Troupis G; Skandalakis P
Recent Adv Cardiovasc Drug Discov; 2014; 9(2):97-105. PubMed ID: 26152179
[TBL] [Abstract][Full Text] [Related]
2. Statins and myocardial infarction: Type, dose, and administration time: Does it matter?
Papageorgiou N; Zacharia E; Briasoulis A; Androulakis E; Tousoulis D
Trends Cardiovasc Med; 2016 Jul; 26(5):433-41. PubMed ID: 26948202
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
Saib A; Sabbah L; Perdrix L; Blanchard D; Danchin N; Puymirat E
Arch Cardiovasc Dis; 2013 Oct; 106(10):511-6. PubMed ID: 24080324
[TBL] [Abstract][Full Text] [Related]
4. Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials.
Naci H; Brugts JJ; Fleurence R; Tsoi B; Toor H; Ades AE
Eur J Prev Cardiol; 2013 Aug; 20(4):641-57. PubMed ID: 23447425
[TBL] [Abstract][Full Text] [Related]
5. Statins in the primary and secondary prevention of cardiovascular disease in women: facts and myths.
Virani SS
Tex Heart Inst J; 2013; 40(3):288-9. PubMed ID: 23914021
[No Abstract] [Full Text] [Related]
6. Cellular and molecular mechanisms of statins: an update on pleiotropic effects.
Satoh M; Takahashi Y; Tabuchi T; Minami Y; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
Clin Sci (Lond); 2015 Jul; 129(2):93-105. PubMed ID: 25927679
[TBL] [Abstract][Full Text] [Related]
7. [Statins in the management of acute coronary syndrome].
Matoba T; Egashira K
Nihon Rinsho; 2010 Apr; 68(4):692-8. PubMed ID: 20387563
[TBL] [Abstract][Full Text] [Related]
8. Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease: A Population-Based Cohort Study in Finland.
Rannanheimo PK; Tiittanen P; Hartikainen J; Helin-Salmivaara A; Huupponen R; Vahtera J; Korhonen MJ
Value Health; 2015 Sep; 18(6):896-905. PubMed ID: 26409618
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein-dependent and independent effects of statins on prevention of major coronary events: meta-regression of randomized placebo-controlled trials.
Takagi H; Umemoto T;
Int J Cardiol; 2013 Oct; 168(5):4850-3. PubMed ID: 23890857
[No Abstract] [Full Text] [Related]
10. Prognosis and lipid profile improvement by a specialized outpatient clinic for acute coronary syndrome patients.
Cordero A; Bertomeu-González V; Moreno-Arribas J; Castillo J; Quiles J; Bertomeu-Martinez V
Atherosclerosis; 2018 Aug; 275():28-34. PubMed ID: 29852402
[TBL] [Abstract][Full Text] [Related]
11. Ezetimibe + statin: insufficient benefit.
Prescrire Int; 2016 Oct; 25(175):245-246. PubMed ID: 30645833
[TBL] [Abstract][Full Text] [Related]
12. Managing the dyslipidemia of metabolic syndrome: beyond statin therapy.
Jialal I; Smith G
Metab Syndr Relat Disord; 2012 Jun; 10(3):159-60. PubMed ID: 22568574
[No Abstract] [Full Text] [Related]
13. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
Giugliano RP; Cannon CP; Blazing MA; Nicolau JC; Corbalán R; Špinar J; Park JG; White JA; Bohula EA; Braunwald E;
Circulation; 2018 Apr; 137(15):1571-1582. PubMed ID: 29263150
[TBL] [Abstract][Full Text] [Related]
14. Patients with Acute Coronary Syndrome are at High Risk Prior to the Event and Lipid Management is Underachieved Pre- and Post- Hospitalization.
Vlachopoulos C; Andrikopoulos G; Terentes-Printzios D; Tzeis S; Iliodromitis EK; Richter D; Mantas I; Kartalis A; Vasilikos V; Stakos D; Patsilinakos S; Lampropoulos S; Symeonidis D; Kyrpizidis C; Marinakis N; Nikas N; Lekakis J; Tousoulis D; Vardas P
Curr Vasc Pharmacol; 2018; 16(4):405-413. PubMed ID: 28676022
[TBL] [Abstract][Full Text] [Related]
15. Statins in the primary prevention of cardiovascular disease.
Reiner Ž
Nat Rev Cardiol; 2013 Aug; 10(8):453-64. PubMed ID: 23736519
[TBL] [Abstract][Full Text] [Related]
16. Statins: have we found the Holy Grail?
Jeger R; Dieterle T
Swiss Med Wkly; 2012; 142():w13515. PubMed ID: 22315166
[TBL] [Abstract][Full Text] [Related]
17. Statins and prevention of venous thromboembolism: Myth or reality?
Gaertner S; Cordeanu EM; Nouri S; Mirea C; Stephan D
Arch Cardiovasc Dis; 2016 Mar; 109(3):216-22. PubMed ID: 26778087
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritis.
Mantel Ä; Holmqvist M; Jernberg T; Wållberg-Jonsson S; Askling J
Ann Rheum Dis; 2017 Dec; 76(12):2017-2024. PubMed ID: 28823986
[TBL] [Abstract][Full Text] [Related]
19. Residual risk and high-density lipoprotein cholesterol levels: is there a relationship?
Shah PK
Rev Cardiovasc Med; 2011; 12(2):e55-9. PubMed ID: 21796083
[TBL] [Abstract][Full Text] [Related]
20. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study.
Waheed S; Pollack S; Roth M; Reichek N; Guerci A; Cao JJ
Atherosclerosis; 2016 Dec; 255():193-199. PubMed ID: 27693004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
